An Observational Real World Study on the Efficacy and Safety of Toripalimab Injection Combined With TACE in the Treatment of Extrahepatic Cholangiocarcinoma

Extrahepatic Cholangiocarcinoma Clinical Trial

Official title:
A Single-arm, Open-label, Multi-center Phase II Clinical Study to Evaluate the Safety and Efficacy of Toripalimab Injection Combined With TACE in the Treatment of Extrahepatic Cholangiocarcinoma

Status Recruiting

Clinical Trial Summary

This is an open-label, single-arm, multicenter phase II clinical study to preliminarily observe and evaluate the efficacy and safety of Toripalimab combined with TACE in the treatment of extrahepatic cholangiocarcinoma.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05448183
Study type	Interventional
Source	The First Affiliated Hospital of Zhengzhou University
Contact	Hua xu Duan, Doctor
Phone	0086-13523402912
Email	xuhuaduan@163.com
Status	Recruiting
Phase	Phase 2
Start date	June 15, 2022
Completion date	May 15, 2024

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05009953` - Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer	Phase 2
Recruiting	`NCT06101277` - Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)	N/A
Active, not recruiting	`NCT04333927` - Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder Cancer	Phase 2
Recruiting	`NCT04561453` - Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
Not yet recruiting	`NCT06440993` - Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma	Phase 2
Active, not recruiting	`NCT02103179` - VEGF Signaling Promotes Cell Growth and Metastasis in Extrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway (ECC)	N/A
Recruiting	`NCT05519319` - Safety and Efficacy of PDT vs RFA vs PDT+RFA for the Treatment of Extrahepatic Cholangiocarcinoma	N/A
Enrolling by invitation	`NCT05233293` - Spyglass+RFA Versus Cytobrush+RFA for Extrahepatic Cholangiocarcinoma	N/A
Recruiting	`NCT05712356` - A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors	Phase 2